Upstream Bio
Waltham, MA
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. They are clinical-stage monoclonal antibodies that inhibit the TSLP receptor, a validated target located upstream of various signaling cascades that influence a range of immune cells that are important in common and unusual illnesses.
upstreambio.comCompany Details
Founded
- 2021
Employees
- Between 20 - 50 employees
Raised
- $408,000,000
Headquarters Location
- Waltham, MA
Public
- No
Acquired
- No
CEO
Rand Sutherland
Founders
- Eran PerryOren Becker
Company Collections
These are collections Upstream Bio is a part of. Click on the collection name to view similar companies.